Hrt Financial LP Catalyst Biosciences, Inc. Transaction History

Hrt Financial LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.19 - $0.64 $15,551 - $52,384	81,851 New	81,851 $16,000
Q4 2021 Feb 14, 2022	SELL	$0.91 - $4.16 $48,947 - $223,758	-53,788 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$3.78 - $5.18 $136,125 - $186,542	-36,012 Reduced 40.1%	53,788 $221,000
Q2 2021 Aug 16, 2021	BUY	$4.1 - $5.33 $368,179 - $478,634	89,800 New	89,800 $388,000

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.